Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 70356-70357 [E8-27532]

Download as PDF 70356 Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Respondents Physicians ........................................................................................................ Dated: November 14, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–27619 Filed 11–19–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. rwilkins on PROD1PC63 with NOTICES Name of Committee: National Human Genome Research Institute Special Emphasis Panel Site Visit (Stanford University). Date: December 12, 2008. Time: 8 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892. Contact Person: Keith McKenney, PhD, Scientific Review Officer, NHGRI, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20814, 301–594–4280, mckenneyk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: November 12, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–27382 Filed 11–19–08; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 18:26 Nov 19, 2008 Jkt 217001 300 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance. Date: December 15, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Crowne Plaza—Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301– 402–3938, lr228v@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance. Date: December 16, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Crowne Plaza—Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301– 402–3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 2 Total burden (in hours) 3/60 30 Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 13, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–27531 Filed 11–19–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of dual use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security. The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend should register online at www.biosecurityboard.gov/ meetings.asp or by calling Capital Consulting Corporation (Contact: Saundra Bromberg at 301–468–6004, ext. 406). Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration. Name of Committee: National Science Advisory Board for Biosecurity Date: December 10, 2008 Open: 8:30 a.m. to 6 p.m. Agenda: Presentations and discussions regarding: (1) Preliminary findings and recommendations on strategies to optimize programs of personnel reliability for individuals with access to select agents and toxins; (2) brief overview of Public E:\FR\FM\20NON1.SGM 20NON1 Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices Consultation meeting in July 2008 on the proposed framework for the oversight of dual use research; (3) brief update on the activities of the Working Group on Outreach and Education; (4) brief update on Synthetic Genomics; (5) highlights from the November 2008 International Roundtable on Sustaining Progress in the Life Sciences: Strategies for Managing Dual Use Research of Concern; (6) public comments; and (7) other business of the Board. Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Ronna Hill, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 496–9838. This meeting will also be webcast. The draft meeting agenda and other information about NSABB, including information about access to the Web cast and pre-registration, will be available at http:// www.biosecurityboard.gov/meetings.asp. Please check the OBA Web site for updates. Times are approximate and subject to change. Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by December 1, 2008 and should be sent via email to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Ronna Hill. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: November 13, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–27532 Filed 11–19–08; 8:45 am] BILLING CODE 4140–01–P dated October 23, 2007, and related determinations. DATES: Effective Date: March 31, 2008. FOR FURTHER INFORMATION CONTACT: Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. Notice is hereby given that the incident period for this emergency is closed effective March 31, 2008. SUPPLEMENTARY INFORMATION: (The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households in Presidential Declared Disaster Areas; 97.049, Presidential Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050, Presidential Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.) R. David Paulison, Administrator, Federal Emergency Management Agency. [FR Doc. E8–27574 Filed 11–19–08; 8:45 am] DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [FEMA–1800–DR] rwilkins on PROD1PC63 with NOTICES VerDate Aug<31>2005 18:26 Nov 19, 2008 Jkt 217001 DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency Indiana; Amendment No. 19 to Notice of a Major Disaster Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: EFFECTIVE DATE: Effective Date: November 13, FOR FURTHER INFORMATION CONTACT: Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration for the State of Illinois is hereby amended to include the following area among those PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 November 13, 2008. FOR FURTHER INFORMATION CONTACT: 2008. SUMMARY: This notice amends the notice of an emergency declaration for the State of California (FEMA–3279–EM), BILLING CODE 9111–23–P Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: DATES: Federal Emergency Management Agency, DHS. ACTION: Notice. R. David Paulison, Administrator, Federal Emergency Management Agency. [FR Doc. E8–27571 Filed 11–19–08; 8:45 am] Illinois; Amendment No. 4 to Notice of a Major Disaster Declaration [FEMA–3279–EM] AGENCY: Peoria County for Individual Assistance. The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance— Disaster Housing Operations for Individuals and Households; 97.050, Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant. SUMMARY: This notice amends the notice of a major disaster declaration for the State of Indiana (FEMA–1766–DR), dated June 8, 2008, and related determinations. Federal Emergency Management Agency California; Amendment No. 2 to Notice of an Emergency Declaration areas determined to have been adversely affected by the event declared a major disaster by the President in his declaration of October 3, 2008. [FEMA–1766–DR] BILLING CODE 9111–23–P SUMMARY: This notice amends the notice of a major disaster declaration for the State of Illinois (FEMA–1800–DR), dated October 3, 2008, and related determinations. DEPARTMENT OF HOMELAND SECURITY 70357 Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Administrator, under Executive Order 12148, as amended, Regis Leo Phelan, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. This action terminates my appointment of Stephen M. DeBlasio, Sr. as Federal Coordinating Officer for this disaster. E:\FR\FM\20NON1.SGM 20NON1

Agencies

[Federal Register Volume 73, Number 225 (Thursday, November 20, 2008)]
[Notices]
[Pages 70356-70357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Science Advisory Board for Biosecurity (NSABB). Under 
authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, 
as amended, the Department of Health and Human Services established 
NSABB to provide advice, guidance and leadership regarding federal 
oversight of dual use research, defined as biological research with 
legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend should register online at www.biosecurityboard.gov/meetings.asp 
or by calling Capital Consulting Corporation (Contact: Saundra Bromberg 
at 301-468-6004, ext. 406). Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should indicate these requirements upon 
registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity
    Date: December 10, 2008
    Open: 8:30 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Preliminary 
findings and recommendations on strategies to optimize programs of 
personnel reliability for individuals with access to select agents 
and toxins; (2) brief overview of Public

[[Page 70357]]

Consultation meeting in July 2008 on the proposed framework for the 
oversight of dual use research; (3) brief update on the activities 
of the Working Group on Outreach and Education; (4) brief update on 
Synthetic Genomics; (5) highlights from the November 2008 
International Roundtable on Sustaining Progress in the Life 
Sciences: Strategies for Managing Dual Use Research of Concern; (6) 
public comments; and (7) other business of the Board.

    Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ronna Hill, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the Web cast and pre-registration, will be available at http://
www.biosecurityboard.gov/meetings.asp. Please check the OBA Web site 
for updates. Times are approximate and subject to change.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by December 1, 2008 
and should be sent via e-mail to nsabb@od.nih.gov with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Ronna 
Hill. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.

    Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-27532 Filed 11-19-08; 8:45 am]
BILLING CODE 4140-01-P